Skip to content
PubMed This is a summary of 45 peer-reviewed journal articles Updated
Neurology · CLCN4-Related Neurodevelopmental Disorder

CLCN4-Related Neurodevelopmental Disorder: A Patient Guide

At a Glance

CLCN4-related neurodevelopmental disorder is a rare genetic condition with wide-ranging effects on development, speech, seizures, behavior, movement, and digestion. Early communication tools such as AAC and coordinated care can support each child’s strengths and needs.

Finding out that your child has CLCN4-related neurodevelopmental disorder places you in a small, global community of families navigating a very rare genetic condition. Because the disorder was only recently identified, you may find that many doctors are still learning about it alongside you. At its core, this condition is caused by a change, or variant, in the CLCN4 gene, which provides the instructions for an endosomal chloride/proton (2Cl−/H+) exchanger—a protein that helps regulate the internal environment of brain cells. When this exchanger doesn’t work correctly, it disrupts how neurons communicate and grow, leading to the diverse developmental and neurological challenges seen in this disorder [1][2].

One of the most important things to understand is that the condition exists on a broad and unpredictable spectrum. While it follows an X-linked inheritance pattern, it is a misconception that only males are severely affected. In CLCN4, heterozygous females can range from apparently unaffected to experiencing symptoms just as profound as males, and standard blood tests used to predict severity in other X-linked conditions often do not reflect how the disorder is actually affecting a girl’s brain [1][3]. Because every child’s genetic “typo” is unique, and published numbers come from small clinical series rather than population rates, your child’s journey will be defined by their own individual strengths and needs rather than a rigid set of statistics [4][5].

Communication is often the area where families focus the most energy. Almost all children with this diagnosis experience significant delays in speech and language, and many may remain nonspeaking or use few spoken words into adulthood. However, research shows that these children are typically intentional communicators—they have a strong desire to connect and share their world [6]. Early support through Augmentative and Alternative Communication (AAC), which uses tools like picture boards or specialized tablets, can be transformative. These tools do not replace speech; instead, they provide a vital bridge that allows your child to express their thoughts and reduce the frustration of being misunderstood [6]. Speech ability does not measure understanding, intelligence, or the value of AAC.

Beyond communication, managing epilepsy is a primary focus for more than half of those diagnosed. Seizures often begin in the first year of life and can take many forms, from brief muscle jerks to more complex episodes that may be resistant to initial medications [4][7]. Because of this complexity, and because the condition can also involve behavioral changes, movement issues, and gastrointestinal distress, a multidisciplinary team of specialists—including neurologists, therapists, and dietitians—is essential. This team works together to support your child’s total well-being, ensuring that every aspect of their health is monitored so they can reach their quality-of-life goals [8][5].

Common questions in this guide

What causes CLCN4-related neurodevelopmental disorder?
It is caused by a change, or variant, in the CLCN4 gene, which helps regulate the internal environment of brain cells. The condition follows an X-linked inheritance pattern and can affect development, communication, seizures, and other areas of health.
Can girls be seriously affected by a CLCN4 variant?
Yes. Girls and women with one altered copy of CLCN4 can have no obvious symptoms or can be affected as significantly as males. Routine blood tests may not predict how the variant is affecting the brain.
Does not speaking mean my child does not understand?
No. Speech ability does not reliably measure understanding, intelligence, or the value of a child’s communication. Many children with CLCN4-related disorder are intentional communicators, and AAC such as picture boards or specialized tablets can help them express needs and ideas.
What seizure symptoms should families watch for?
Seizures are common and often begin in the first year of life, but they can take different forms. Brief muscle jerks, blank stares, or more complex episodes should be discussed promptly with the child’s clinician, who may recommend an EEG.
What specialists may help a child with CLCN4 disorder?
Care often involves a multidisciplinary team, which may include a neurologist, therapists, and a dietitian. The team can address seizures, communication, behavior, movement, feeding, and gastrointestinal concerns, with one clinician helping coordinate the overall plan.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on CLCN4-related X-linked intellectual disability syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given that CLCN4 symptoms vary so much, what does my child's specific genetic variant suggest about their likely developmental path, recognizing that predictions are uncertain?
  2. 2.Since females can be severely affected regardless of blood test results, how should we monitor my daughter's development compared to a typical X-linked carrier?
  3. 3.What specific 'intentional communication' behaviors are you seeing in my child, and how can we start an AAC evaluation now?
  4. 4.Does my child need an EEG based on our clinical observations, given how common epilepsy is in this condition?
  5. 5.Who will be the 'medical home' or lead coordinator for our multidisciplinary team of specialists?

References

References (8)
  1. 1

    De novo and inherited mutations in the X-linked gene CLCN4 are associated with syndromic intellectual disability and behavior and seizure disorders in males and females.

    Palmer EE, Stuhlmann T, Weinert S, et al.

    Molecular psychiatry 2018; (23(2)):222-230 doi:10.1038/mp.2016.135.

    PMID: 27550844
  2. 2

    Genotype-phenotype correlation in CLCN4-related developmental and epileptic encephalopathy.

    Sahly AN, Sierra-Marquez J, Bungert-Plümke S, et al.

    Human genetics 2024; (143(5)):667-681 doi:10.1007/s00439-024-02668-z.

    PMID: 38578438
  3. 3

    Novel variants in the CLCN4 gene associated with syndromic X-linked intellectual disability.

    Li S, Zhang W, Liang P, et al.

    Frontiers in neurology 2023; (14()):1096969 doi:10.3389/fneur.2023.1096969.

    PMID: 37789889
  4. 4

    The molecular and phenotypic spectrum of CLCN4-related epilepsy.

    He H, Guzman RE, Cao D, et al.

    Epilepsia 2021; (62(6)):1401-1415 doi:10.1111/epi.16906.

    PMID: 33951195
  5. 5

    Functional and clinical studies reveal pathophysiological complexity of CLCN4-related neurodevelopmental condition.

    Palmer EE, Pusch M, Picollo A, et al.

    Molecular psychiatry 2023; (28(2)):668-697 doi:10.1038/s41380-022-01852-9.

    PMID: 36385166
  6. 6

    CLCN4 -Related Neurodevelopmental Condition: Characterization of Speech and Language Abilities.

    Garrett A, Kalscheuer VM, Figueroa RR, et al.

    American journal of medical genetics. Part A 2025; (197(12)):e64192 doi:10.1002/ajmg.a.64192.

    PMID: 40762462
  7. 7

    Expanding the genetic and phenotypic relevance of CLCN4 variants in neurodevelopmental condition: 13 new patients.

    He H, Li X, Guzman GA, et al.

    Journal of neurology 2024; (271(8)):4933-4948 doi:10.1007/s00415-024-12383-4.

    PMID: 38758281
  8. 8

    Expanding the Phenotypic Spectrum of Raynaud-Claes Syndrome: A Rett-like Presentation with Two New Cases.

    Milone R, Orsini A, Marinella G, et al.

    Genes 2026; (17(6)) doi:10.3390/genes17060623.

    PMID: 42353781

This page explains CLCN4-related neurodevelopmental disorder for educational purposes and is not medical advice. A child’s neurologist, geneticist, and care team should interpret their symptoms and plan individualized evaluation and support.